318 related articles for article (PubMed ID: 34447671)
1. May mesenchymal stem cell transplantation be a solution for COVID-19 induced cytokine storm?
Sütlüoğlu H; Özdemir Ö
World J Transplant; 2021 Aug; 11(8):344-355. PubMed ID: 34447671
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.
Eskandarian Boroujeni M; Sekrecka A; Antonczyk A; Hassani S; Sekrecki M; Nowicka H; Lopacinska N; Olya A; Kluzek K; Wesoly J; Bluyssen HAR
Front Immunol; 2022; 13():888897. PubMed ID: 35663932
[TBL] [Abstract][Full Text] [Related]
3. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
Atluri S; Manchikanti L; Hirsch JA
Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections.
Liu T; Feng M; Wen Z; He Y; Lin W; Zhang M
J Inflamm Res; 2021; 14():5475-5487. PubMed ID: 34720596
[TBL] [Abstract][Full Text] [Related]
5. The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System.
Ellison-Hughes GM; Colley L; O'Brien KA; Roberts KA; Agbaedeng TA; Ross MD
Front Cardiovasc Med; 2020; 7():602183. PubMed ID: 33363221
[TBL] [Abstract][Full Text] [Related]
6. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
7. Immune Profiling of COVID-19 in Correlation with SARS and MERS.
Khalil BA; Shakartalla SB; Goel S; Madkhana B; Halwani R; Maghazachi AA; AlSafar H; Al-Omari B; Al Bataineh MT
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062368
[TBL] [Abstract][Full Text] [Related]
8. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
Jafarzadeh A; Chauhan P; Saha B; Jafarzadeh S; Nemati M
Life Sci; 2020 Sep; 257():118102. PubMed ID: 32687918
[TBL] [Abstract][Full Text] [Related]
9. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.
Coperchini F; Chiovato L; Croce L; Magri F; Rotondi M
Cytokine Growth Factor Rev; 2020 Jun; 53():25-32. PubMed ID: 32446778
[TBL] [Abstract][Full Text] [Related]
10. An enlightening role for cytokine storm in coronavirus infection.
Zhao Z; Wei Y; Tao C
Clin Immunol; 2021 Jan; 222():108615. PubMed ID: 33203513
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cell therapy for COVID-19.
Sengul F; Ozturk B; Vatansev H
Am J Stem Cells; 2021; 10(5):79-89. PubMed ID: 35103115
[TBL] [Abstract][Full Text] [Related]
12. Review of Trials Currently Testing Stem Cells for Treatment of Respiratory Diseases: Facts Known to Date and Possible Applications to COVID-19.
Majolo F; da Silva GL; Vieira L; Timmers LFSM; Laufer S; Goettert MI
Stem Cell Rev Rep; 2021 Feb; 17(1):44-55. PubMed ID: 32827081
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of MSC in Patients with Severe COVID-19: Analysis of the Literature and a Case Study.
Grumet M; Sherman J; Dorf BS
Stem Cells Transl Med; 2022 Nov; 11(11):1103-1112. PubMed ID: 36181766
[TBL] [Abstract][Full Text] [Related]
14. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH
Front Immunol; 2020; 11():1022. PubMed ID: 32574260
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.
Olbei M; Hautefort I; Modos D; Treveil A; Poletti M; Gul L; Shannon-Lowe CD; Korcsmaros T
Front Immunol; 2021; 12():629193. PubMed ID: 33732251
[TBL] [Abstract][Full Text] [Related]
16. Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome.
Rossi M; Piagnerelli M; Van Meerhaeghe A; Zouaoui Boudjeltia K
Med Hypotheses; 2020 Nov; 144():110242. PubMed ID: 33254548
[TBL] [Abstract][Full Text] [Related]
17. Direct comparison of different therapeutic cell types susceptibility to inflammatory cytokines associated with COVID-19 acute lung injury.
Vaka R; Khan S; Ye B; Risha Y; Parent S; Courtman D; Stewart DJ; Davis DR
Stem Cell Res Ther; 2022 Jan; 13(1):20. PubMed ID: 35033181
[TBL] [Abstract][Full Text] [Related]
18. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging".
Meftahi GH; Jangravi Z; Sahraei H; Bahari Z
Inflamm Res; 2020 Sep; 69(9):825-839. PubMed ID: 32529477
[TBL] [Abstract][Full Text] [Related]
19. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.
Wang J; Jiang M; Chen X; Montaner LJ
J Leukoc Biol; 2020 Jul; 108(1):17-41. PubMed ID: 32534467
[TBL] [Abstract][Full Text] [Related]
20. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
Can A; Coskun H
Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
